By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Duke Clinical Research Institute 

2400 Pratt Street

Durham  North Carolina  27705   U.S.A.
Phone: 919-668-8700 Fax: 919-668-7070


For over three decades, the Duke Clinical Research Institute has been helping the pharmaceutical, medical device, and biotech industries develop new therapeutic options. We offer a unique combination of clinical expertise, academic leadership, operational capabilities, and business acumen that translates into targeted and sound research results. With thought-leaders capable of staying at the cutting edge of science and the business of the industry, our efforts consistently help sponsors be first to market and first to peak sales. The DCRI achieves this by integrating scientific thought-leadership with full-service operational capabilities in Phase I-IV multi-center clinical trials and outcomes research. Over 800 employees collaborate across all disciplines to create successful projects.

Breadth and Depth

The DCRI enlists more than 5000 investigators in over 70 countries to carry out scientific investigations, reflecting the DCRI's tremendous experience and knowledge of the cultural differences in clinical practice and clinical research capabilities. More than a decade of globe-spanning trials experience means smooth oversight across time and geography. Though best known for our pioneering research in cardiology, DCRI research spans the scientific gamut, from pediatrics to geriatrics, primary care to subspecialty medicine, and genomics and proteomics. In recent years, our expertise in infectious disease, oncology, and central nervous system research has grown tremendously. Our knowledge and experience continue to expand and now encompass the following:

* Anesthesiology * Otolaryngology
* Cardiology * Pediatrics
* Cardiothoracic surgery * Pulmonary medicine
* Endocrinology * Primary care
* Gastroenterology * Psychiatry
* Geriatrics * Reproductive
* Hematology medicine
* Infectious disease * Rheumatology
* Nephrology * Transplant medicine
* Oncology * Women's health
* Ophthalmology

Last Updated: 06-09-05

Key Statistics

Ownership: Private

Web Site: Duke Clinical Research Institute

Company News
Duke Clinical Research Institute Release: New Collaborative Effort Aims To Improve Adult Vaccination Rates Within Primary Care Setting 8/31/2016 2:18:53 PM
Boehringer Ingelheim And Duke Clinical Research Institute Expand Collaboration To Create Largest Patient Registry For Idiopathic Pulmonary Fibrosis (IPF) 8/25/2016 9:36:54 AM
Duke Clinical Research Institute To Support Clinical Trials With Vitalhealth Questlink 9/21/2015 1:14:36 PM
Boehringer Ingelheim Corporation And Duke Clinical Research Institute Form Collaborative Partnership To Study The Natural History Of Idiopathic Pulmonary Fibrosis (IPF) 1/30/2014 10:44:11 AM
Oxygen Biotherapeutics, Inc. (OXBO) Selects Duke Clinical Research Institute To Conduct Phase 3 Trial Of Levosimendan 12/11/2013 9:00:44 AM
Copernicus Group IRB Collaborating With Drug Information Association and Duke Clinical Research Institute Unit on Global Clinical Trial Conference 4/23/2012 1:08:51 PM
Study Shows Balloon Pump Use Prior to Angioplasty Does Not Reduce Heart Muscle Damage, Duke Clinical Research Institute Study 8/30/2011 7:19:05 AM
New Agent Prevents Stroke in Patients With Atrial Fibrillation, Duke Clinical Research Institute Study Suggests 8/11/2011 7:07:47 AM
Tethys Bioscience, Inc. and Duke Clinical Research Institute Establish PREVAIL Initiative to Improve Care and Reduce Incidence of Type 2 Diabetes 3/30/2011 10:11:20 AM
Higher Education May Benefit Some Heart Attack Patients, Duke Clinical Research Institute and Duke University Medical Center Study 1/5/2011 7:45:02 AM